ROYAL BANK OF CANADA - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 81 filers reported holding CUE BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q2 2024$0
-100.0%
143
-85.7%
0.00%
Q1 2024$2,000
-93.9%
1,000
-92.0%
0.00%
Q4 2023$33,000
+37.5%
12,460
+20.7%
0.00%
Q3 2023$24,000
+200.0%
10,323
+381.3%
0.00%
Q2 2023$8,0002,145
+879.5%
0.00%
Q3 2022$0219
+995.0%
0.00%
Q2 2022$0
-100.0%
20
-99.2%
0.00%
Q1 2022$13,000
-82.9%
2,660
-60.3%
0.00%
Q4 2021$76,000
+81.0%
6,699
+135.0%
0.00%
Q3 2021$42,000
+75.0%
2,851
+39.8%
0.00%
Q2 2021$24,000
-11.1%
2,039
-8.5%
0.00%
Q1 2021$27,000
+800.0%
2,229
+998.0%
0.00%
Q4 2020$3,000
+200.0%
203
+322.9%
0.00%
Q3 2020$1,0000.0%48
+17.1%
0.00%
Q2 2020$1,000
-50.0%
41
-62.7%
0.00%
Q1 2020$2,000
-92.3%
110
-93.3%
0.00%
Q4 2019$26,0000.0%1,637
-41.7%
0.00%
Q3 2018$26,000
-50.0%
2,808
-34.8%
0.00%
Q2 2018$52,0004,3050.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Corriente Advisors, LLC 1,437,445$21,634,00010.97%
Prosight Management, LP 709,936$10,685,0005.08%
Voss Capital, LP 226,573$3,410,0001.94%
Robertson Stephens Wealth Management, LLC 484,000$7,284,0001.79%
Slate Path Capital LP 1,483,619$22,328,0001.27%
Nantahala Capital Management 2,342,216$35,250,0001.08%
SANDERS MORRIS HARRIS LLC 142,430$2,312,0000.63%
Rock Creek Group, LP 80,000$1,204,0000.62%
PRECEPT MANAGEMENT LLC 150,000$2,258,0000.55%
PA Capital LLC 46,850$705,0000.50%
View complete list of CUE BIOPHARMA INC shareholders